News & Articles

Clinical laboratories certified to perform high complexity tests under Clinical Laboratory Improvement Amendments (CLIA) can immediately begin using this ELISA

Register today to reserve a place at the Summit - it opens at 13:00 (BST) / 14:00 (CEST) / 08:00 (EDT) / 05:00 (PDT) on Monday, May 11

AMSBIO's new service utilizes their novel lentiviral system to aid the development of therapeutic drugs and vaccines

Preliminary results from a government-sponsored study suggest that drug used to treat Ebola may help COVID-19 patients

The blood-based immunoassay test enables clinicians to identify the virus linked with COVID-19

Bio-Rad Laboratories has launched a range of anti-certolizumab pegol inhibitory antibodies to support the development of anti-drug antibody (ADA) assays

The serology test promises 100% sensitivity and can help assess patients' immune response to the virus

The molecular test kit promises 100% diagnostic sensitivity and specificity, and is authorized for clinical practice use in Europe

The antibody test, which has a potential time to result of 14 minutes, will join the rest of the company's diagnostic portfolio

The company aims to provide solutions for the pandemic through close collaboration with scientists and providing cutting-edge laboratory equipment

Learn more about how BINDER is helping countless laboratories across the world conduct research into coronavirus.

Collaboration will enable global development, manufacturing and distribution of the vaccine

These models aim to accelerate treatment development prior to clinical trials

The test will be available for qualified laboratories across the European Union by the end of May

Leinco Technologies will co-develop a rapid, point of care, immunodiagnostic test for the detection of the SARS-CoV-2 virus responsible for COVID-19

Join this expert webinar to find out about applications for cell-based therapies and biologics using advanced high-throughput flow cytometry

Following regulatory approval, the first clinical trial of the coronavirus vaccine candidates is said to commence in late April

Pioneering new class of diagnostic product will transform fight against pandemic

Catch up on this on-demand webinar to learn how researchers at LifeArc are investigating a novel approach to targeting ALK-expressing neuroblastoma cells

The AIHTA have published a comprehensive overview of current research and development activities for evidence-based policy advice

Single-cell analysis for therapeutic discovery recognized with prestigious business award for innovation